Trial intelligence / Profile preview

Long-term Follow-up of ATX-101 for Submental Fat

NCT02159729Phase 2Completed

Sponsor
Kythera Biopharmaceuticals
Start
Feb 2009
Primary completion
Dec 2015
Modality
Small Molecules
Countries
4
01

Overview

A Phase 2 trial of sodium deoxycholate in submental fat, sponsored by Kythera Biopharmaceuticals. Started Feb 2009; status: completed.

02

Drugs

sodium deoxycholate
03

Conditions

submental fat

Beyond the preview

Go deeper on NCT02159729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02159729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call